• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: Man lives 105 days with Artificial Heart (BiVACOR) before transplant-what you should know
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > ME Explained > Man lives 105 days with Artificial Heart (BiVACOR) before transplant-what you should know
ME Explained

Man lives 105 days with Artificial Heart (BiVACOR) before transplant-what you should know

Harshad Hussain B
Harshad Hussain B
Published: March 20, 2025
Share
4 Min Read
BiVACOR
Image Credit: BiVACORยฎ
SHARE

In November 2024, a man in his 40s, choosing to remain anonymous, made medical history as the first person discharged from a hospital with a fully artificial heart. At St Vincentโ€™s Hospital in Sydney, surgeons performed a groundbreaking six-hour procedure, implanting the titanium-crafted BiVACOR Total Artificial Heart (TAH) to save him from severe heart failure. After weeks in intensive care and further monitoring, he left the hospital in early February. For 105 days, he lived with the artificial heart pumping in his chest until March 6, when a donor heart became available for transplant. His doctors report heโ€™s recovering strongly, an outcome to this innovative technology.ย 

Contents
  • What is Total Artificial Heart?
  • What is a Titanium Heart?
  • BiVACOR Total Artificial Heart
  • Brief History of Artificial Hearts

Letโ€™s go over some basic information about artificial hearts.

What is Total Artificial Heart?

A total artificial heart is a device implanted in the chest to replace the heartโ€™s damaged ventricles and valves. Made from durable and flexible polyurethane, it functions as a pump to maintain blood circulation. An external machine, known as a driver, controls the pump to ensure blood flows properly throughout the body. Primarily used as a temporary solution, it serves as a bridge to transplant, keeping patients stable while they await a donor heart.

What is a Titanium Heart?

A titanium heart refers to an advanced artificial heart, like the BiVACOR Total Artificial Heart, crafted from durable titanium. Implanted to replace a failing heart, it pumps blood using a magnetically levitated rotor, offering a temporary lifeline until transplant.

BiVACOR Total Artificial Heart

The BiVACOR Total Artificial Heart is a new kind of heart pump made by a company started by an Australian engineer, Daniel Timms. It helps people whose hearts donโ€™t work well by using a spinning part that floats with magnets to push blood to the body and lungs. Unlike older heart machines, itโ€™s small, strong, and doesnโ€™t need valves. It runs on a battery and a control box outside the body, making blood flow like a real heart does.

Right now, itโ€™s used to keep people alive until they can get a new heart from a donor. It was first put in a person in July 2024 in Texas, and since then, itโ€™s helped several patients in the U.S. and recent one in Australia.

Brief History of Artificial Hearts

The development of artificial hearts dates back to the mid-20th century when scientists and engineers sought mechanical solutions for end-stage heart failure. In 1982, Dr. Barney Clark became the first person to receive a permanent total artificial heart, the Jarvik-7. Although he lived for 112 days, the bulky external components and complications highlighted the need for improvements. Over the following decades, advances in biomaterials, miniaturization, and pump technology led to more refined devices.

In the early 2000s, the SynCardia Total Artificial Heart became the first FDA-approved device for patients awaiting heart transplants, demonstrating improved survival rates. Meanwhile, researchers explored rotary pump designs to mimic natural blood flow better. The BiVACOR Total Artificial Heart represents a major leap in this evolution, replacing traditional pulsatile pumps with a compact, magnetically levitated rotor, reducing wear and tear while ensuring continuous blood circulation.

Also Read : Goldie Hawnโ€™s Oscars revelation: Understanding cataracts and their impact

From early experimental implants to modern-day breakthroughs, artificial hearts have transformed from short-term solutions into increasingly viable long-term alternatives. As technology advances, future designs may one day provide a permanent replacement for biological hearts, offering hope to patients worldwide who lack access to suitable donor organs.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Harshad Hussain B
ByHarshad Hussain B
Follow:
[email protected]
Previous Article Transforming Healthcare with Wellness Pharmacy | Dr. Kathy Campbell’s Insights | Duphat 2025
Next Article ๐Ÿ๐Ÿ๐ญ๐ก ๐€๐ง๐ง๐ฎ๐š๐ฅ ๐’๐–๐€๐€๐‚ ๐„๐‹๐’๐Ž ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž: ๐€ ๐‘๐ž๐ฆ๐š๐ซ๐ค๐š๐›๐ฅ๐ž ๐‚๐จ๐ง๐œ๐ฅ๐ฎ๐ฌ๐ข๐จ๐ง!

Recent Posts

  • From market access to national ambition, gulf healthcare is playing a longer game
  • New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
  • WHO Discusses Digital Health and Humanization of Care at Scientific Conference
  • Rising Ebola Cases Deepen Humanitarian Crisis for Children in DR Congo
  • Burjeel holdings secures dual credit ratings and launches USD 1.5 billion sukuk programme
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Man lives 105 days with Artificial Heart (BiVACOR) before transplant-what you should know
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Man lives 105 days with Artificial Heart (BiVACOR) before transplant-what you should know
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?